01164nam--2200361---450-9900005615602033160056156USA010056156(ALEPH)000056156USA01005615620010712d1969----km-y0itay0103----bafreFR||||||||001yyFondements mathématiques de la reconnaissance des structuresParisHermann1969varia num.ill.24 cmActualités scientifiques et industrielles13422001Actualités scientifiques et industrielles1342511.PAVEL,Monique58130ITsalbcISBD990000561560203316500 ASI 1342 A2739 CBS500 ASI00107495500 ASI 1342 B5410 CBS500 ASI00107496BKSCIPATTY9020010712USA011307PATTY9020010712USA01131720020403USA011705PATRY9020040406USA011639Fondements mathématiques de la reconnaissance des structures380123UNISA01232nam 2200361Ia 450 991070182170332120120620115653.0(CKB)5470000002421894(OCoLC)795912193(EXLCZ)99547000000242189420120620d1993 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierDegradation of shutdown cooling system performance[electronic resource]Washington, D.C. :U.S. Nuclear Regulatory Commission, Office of Nuclear Reactor Regulation,[1993]1 online resourceNRC information notice ;93-45Title from title screen (viewed June 20, 2012)."June 16, 1993."Nuclear reactorsShutdownNuclear reactorsCoolingNuclear reactorsShutdown.Nuclear reactorsCooling.U.S. Nuclear Regulatory Commission.Office of Nuclear Reactor Regulation.GPOGPOBOOK9910701821703321Degradation of shutdown cooling system performance3188999UNINA05401nam 22006854a 450 991101913700332120200520144314.09786610721429978128072142712807214219780470055502047005550297804700554960470055499(CKB)1000000000354777(EBL)281826(SSID)ssj0000242286(PQKBManifestationID)11215414(PQKBTitleCode)TC0000242286(PQKBWorkID)10310304(PQKB)10947325(MiAaPQ)EBC281826(OCoLC)86175956(Perlego)2774706(EXLCZ)99100000000035477720060412d2007 uy 0engur|n|---|||||txtccrScience, society, and the supermarket the opportunities and challenges of nutrigenomics /David Castle ... [et al.]Hoboken, N.J. Wiley-Intersciencec20071 online resource (177 p.)Description based upon print version of record.9780471770008 0471770000 Includes bibliographical references and index.SCIENCE, SOCIETY, AND THE SUPERMARKET; CONTENTS; Preface; Acknowledgments; 1 NUTRITIONAL GENOMICS: OPPORTUNITIES AND CHALLENGES; 1.1 Introduction; 1.2 What is Nutritional Genomics?; 1.3 Methodology and Approach of this Book; 1.4 Opportunities and Challenges for Nutrigenomics; 1.4.1 Improved health; 1.4.2 Personalized dietary advice; 1.4.3 Improved diet; 1.4.4 More development of health-enhancing food products; 1.4.5 Consumer empowerment; 1.4.6 Reducing health disparities; 1.4.7 Health care savings; 1.5 Challenges and a Road Map of This Book; References2 THE SCIENCE OF NUTRIGENOMICS AND NUTRIGENETICS2.1 Introduction; 2.2 The Scientific Context; 2.2.1 Nutrigenomics; 2.2.2 Nutrigenetics; 2.3 The Case of MTHFR; 2.4 Room for Improvement; 2.4.1 Study design; 2.4.2 Epigenetics; 2.4.3 SNPs and haplotypes; 2.4.4 Dietary intake assessment; 2.4.5 Biomarkers; 2.4.6 Susceptibility and predictions; 2.4.7 Analytical and clinical validity; 2.4.8 Clinical utility; 2.5 Science and Technology Assessment; 2.6 Conclusion; References; 3 THE ETHICS OF NUTRIGENOMIC TESTS AND INFORMATION; 3.1 Introduction; 3.2 Ethical Principles3.3 Nutrigenomics Testing in the Clinical Setting3.3.1 Informed consent; 3.3.2 Confidentiality; 3.3.3 Secondary information; 3.3.4 Families; 3.3.5 Genetic testing of children and adolescents; 3.4 Use of Nutrigenomics Information for Research; 3.5 Use of Nutrigenomics Information by Private Third Parties; 3.5.1 Insurance; 3.5.2 Employment; 3.5.3 Legal and social responses to fears of discrimination; 3.6 Conclusion; References; 4 ALTERNATIVES FOR NUTRIGENOMIC SERVICE DELIVERY; 4.1 Introduction; 4.2 Considerations for Nutrigenomic Service Delivery; 4.2.1 Strength of the science4.2.2 Regulatory environment4.2.3 Human resource capacity and professional competence; 4.2.4 Funding policy; 4.2.5 Professional politics and culture; 4.2.6 Consumers and patients; 4.3 Four Alternative Models; 4.3.1 Consumer model; 4.3.2 Health practitioner model; 4.3.3 Blended models; 4.3.4 Public health model; 4.4 Conclusion; References; 5 NUTRIGENOMICS AND THE REGULATION OF HEALTH CLAIMS FOR FOODS AND DRUGS; 5.1 Introduction; 5.1.1 Genetic tests, service delivery, and genetic antidiscrimination; 5.2 Food Categories: Functional Foods, Nutraceuticals, Medicinal Foods, and Dietary Supplements5.2.1 Functional foods5.2.2 Nutraceuticals; 5.2.3 Medical or medicinal foods; 5.2.4 Dietary supplements; 5.3 Health-Related Claims Associated with Foods Compared to Drugs; 5.3.1 Structure-function claims; 5.3.2 Health claims; 5.3.3 Medical food claims; 5.3.4 Disease risk reduction claims; 5.4 Nutrigenomic Information and the Regulation of Foods Compared to Drugs; 5.4.1 The regulation of foods; 5.4.2 The regulation of drugs; 5.5 Food and Drug Regulations in Japan, the United States, and Canada; 5.5.1 Japan; 5.5.2 United States; 5.5.3 Canada; 5.6 Conclusion; References6 NUTRIGENOMICS: JUSTICE, EQUITY, AND ACCESSThe new science of nutrigenomics and its ethical and societal challengesGene-diet interactions--which underlie relatively benign lactose intolerance to life-threatening conditions such as cardiovascular disease--have long been known. But until now, scientists lacked the tools to fully understand the underlying mechanisms that cause these conditions. In recent years, however, strides in human genomics and the nutritional sciences have allowed for the advancement of a new science--dubbed nutrigenomics. Although this science may lead to personalized nutrition and dietary recommendatioNutritionGenetic aspectsFunctional genomicsNutrient interactionsNutritionGenetic aspects.Functional genomics.Nutrient interactions.612.3Castle David1967-1841982MiAaPQMiAaPQMiAaPQBOOK9911019137003321Science, society, and the supermarket4421911UNINA